More Globe Newswire

View Older Stories View Newer Stories

Apr 23, 2024 08:00AM OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors
Apr 23, 2024 08:00AM RTI Earns 2024 Great Place To Work Certification™ in the U.S. and Spain for the Sixth Consecutive Year
Apr 23, 2024 08:00AM INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
Apr 23, 2024 08:00AM Panelite releases product lines for Peterbilt 589
Apr 23, 2024 08:00AM Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Apr 23, 2024 08:00AM Launching Reach 2.0: Next-Gen Event Marketing Platform for Webinars and Field Marketing Events
Apr 23, 2024 08:00AM Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
Apr 23, 2024 08:00AM Coda Octopus Group Reports Sizable Sale of Echoscope PIPE® Sonars to Major Offshore Service Provider.
Apr 23, 2024 08:00AM Energy and Water Development Corp. (EAWD) Appoints Bevilacqua PLLC as SEC and Capital Markets Counsel
Apr 23, 2024 08:00AM Luckin Coffee to Announce First Quarter 2024 Financial Results on April 30, 2024
Apr 23, 2024 08:00AM Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
Apr 23, 2024 08:00AM DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
Apr 23, 2024 08:00AM INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
Apr 23, 2024 08:00AM Clinical ink announces GlucoseReady™
Apr 23, 2024 08:00AM PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
Apr 23, 2024 08:00AM Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
Apr 23, 2024 08:00AM Monarch Private Capital and Elawan Energy Announce Substantial Completion of Two Renewable Energy Projects
Apr 23, 2024 08:00AM G2 Spring 2024 Report: Huntress Claims Dominance in Endpoint and Managed Detection, Named Industry Leader
Apr 23, 2024 08:00AM PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic
Apr 23, 2024 08:00AM Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT
Apr 23, 2024 08:00AM Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
Apr 23, 2024 08:00AM The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
Apr 23, 2024 08:00AM CEX.IO’s Mark Taylor, Global Head of Financial Crime to Join Panel Organized by C5
Apr 23, 2024 08:00AM Arteris to Announce Financial Results for the First Quarter 2024 on Thursday, May 2, 2024
Apr 23, 2024 08:00AM Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
Apr 23, 2024 08:00AM InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024
Apr 23, 2024 08:00AM Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive Vice President and Head of Research and Development, and Strengthens Sci
Apr 23, 2024 08:00AM Esperion to Report First Quarter 2024 Financial Results on May 7
Apr 23, 2024 08:00AM Ensurge Micropower ASA - Notice of Annual General Meeting 14 May 2024
Apr 23, 2024 08:00AM EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Associ
Apr 23, 2024 08:00AM Provident Bank Donates Original Bank Ledgers Dating Back to 1839 to the Jersey City Free Public Library
Apr 23, 2024 07:55AM illumin Announces illumin Elect Enhancement with L2 to Amplify Journey Advertising Capabilities for Political Campaigns
Apr 23, 2024 07:50AM Form 8.3 - UK Commercial Property REIT
Apr 23, 2024 07:48AM Form 8.3 - Tyman plc
Apr 23, 2024 07:45AM Garry Menzel joins GHO Capital as Operating Partner
Apr 23, 2024 07:45AM Trailbreaker Commences Drilling at the Liberty Copper Property, BC.
Apr 23, 2024 07:43AM Form 8.3 - International Distributions Services Plc
Apr 23, 2024 07:36AM Alliance Trust PLC - Net Asset Value
Apr 23, 2024 07:30AM TC Energy provides results of Series 7 Shares conversion elections
Apr 23, 2024 07:30AM Metasphere Labs Inc. Unveils Bitcoin-Based Identity System, and Enters Exclusive Licensing Talks with Bot Ventures Inc.
Apr 23, 2024 07:30AM Midland Amends Its Lithium Option Agreement With Rio Tinto With the Addition of the Wookie Project
Apr 23, 2024 07:30AM BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2023
Apr 23, 2024 07:30AM Canada’s flagship oil and gas media brand relaunches as DOB Energy, with a new visual identity and website
Apr 23, 2024 07:29AM KFSH&RC Announced as Strategic Partner for the Saudi American Healthcare Forum 2024
Apr 23, 2024 07:30AM Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Apr 23, 2024 07:30AM KellyOCG Earns Recognition as a John Deere “Partner-level Supplier”
Apr 23, 2024 07:30AM Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Apr 23, 2024 07:30AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
Apr 23, 2024 07:30AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Luna
Apr 23, 2024 07:30AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
View Newer Stories View Older Stories